Surgical Treatment of Moderate Ischemic Mitral Regurgitation

This trial compared coronary-artery bypass grafting alone with CABG plus mitral-valve repair in patients with coronary artery disease and moderate ischemic mitral regurgitation. Mitral-valve repair provided no apparent benefit and was associated with more neurologic complications. Each year, approxi...

Full description

Saved in:
Bibliographic Details
Published inThe New England journal of medicine Vol. 371; no. 23; pp. 2178 - 2188
Main Authors Smith, Peter K, Puskas, John D, Ascheim, Deborah D, Voisine, Pierre, Gelijns, Annetine C, Moskowitz, Alan J, Hung, Judy W, Parides, Michael K, Ailawadi, Gorav, Perrault, Louis P, Acker, Michael A, Argenziano, Michael, Thourani, Vinod, Gammie, James S, Miller, Marissa A, Pagé, Pierre, Overbey, Jessica R, Bagiella, Emilia, Dagenais, François, Blackstone, Eugene H, Kron, Irving L, Goldstein, Daniel J, Rose, Eric A, Moquete, Ellen G, Jeffries, Neal, Gardner, Timothy J, O'Gara, Patrick T, Alexander, John H, Michler, Robert E
Format Journal Article
LanguageEnglish
Published Waltham, MA Massachusetts Medical Society 04.12.2014
Subjects
Online AccessGet full text
ISSN0028-4793
1533-4406
1533-4406
DOI10.1056/NEJMoa1410490

Cover

More Information
Summary:This trial compared coronary-artery bypass grafting alone with CABG plus mitral-valve repair in patients with coronary artery disease and moderate ischemic mitral regurgitation. Mitral-valve repair provided no apparent benefit and was associated with more neurologic complications. Each year, approximately 1 million Americans have a myocardial infarction, and nearly 8 million Americans have a history of myocardial infarction. 1 Ischemic mitral regurgitation, which results from functional-valve incompetence due to myocardial injury and adverse left ventricular remodeling, develops in approximately 50% of patients after an infarction, and moderate regurgitation occurs in more than 10% of patients. 2 – 4 Ischemic mitral regurgitation is associated with excess mortality regardless of management. 5 , 6 The valve leaflets and chordal structures in affected patients are “innocent bystanders”; mitral regurgitation results from papillary muscle displacement, leaflet tethering, reduced closing forces, and annular dilatation. 7 – 10 Many patients . . .
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Undefined-3
The Cardiothoracic Surgical Trials Network investigators are listed in the Supplementary Appendix, available at NEJM.org.
ISSN:0028-4793
1533-4406
1533-4406
DOI:10.1056/NEJMoa1410490